F Braza1,2,3,4,5,6, J Chesne1,2,3,4,5,6, M Durand3,4,5,6, S Dirou1,2,7, C Brosseau1,2,3,4,7, G Mahay1,2, M A Cheminant1,2, A Magnan1,2,6,7, S Brouard3,4,5,6. 1. INSERM, UMR 1087, l'institut du thorax, Nantes, France. 2. CNRS, UMR 6291, Nantes, France. 3. INSERM, UMR 1064, Nantes, France. 4. CHU de Nantes, ITUN, Nantes, France. 5. CIC biothérapie, Nantes, France. 6. Université de Nantes, Nantes, France. 7. CHU Nantes, l'institut du thorax, Service de Pneumologie, Nantes, France.
Abstract
BACKGROUND: Exposure to respiratory allergens triggers airway hyperresponsiveness and inflammation characterized by the expansion of TH 2 cells and the production of allergen specific IgE. Allergic asthma is characterized by an alteration in immune regulatory mechanisms leading to an imbalance between pro- and anti-inflammatory components of the immune system. AIMS: Recently B cells have been described as central regulators of exacerbated inflammation, notably in the case of autoimmunity. However, to what extent these cells can regulate airway inflammation and asthma remains to be elucidated. MATERIALS & METHODS: We took advantage of a allergic asthma model in mice induced by percutaneous sensitization and respiratory challenge with an extract of house dust mite. RESULTS: In this study, we showed that the induction of allergic asthma alters the homeostasis of IL-10(+) Bregs and favors the production of inflammatory cytokines by B cells. Deeper transcriptomic and phenotypic analysis of Bregs revealed that they were enriched in a CD9(+) B cell subset. In asthmatic mice the adoptive transfer of CD9(+) B cells normalized airway inflammation and lung function by inhibiting TH 2- and TH 17-driven inflammation in an IL-10-dependent manner, restoring a favorable immunological balance in lung tissues. Indeed we further showed that injection of CD9(+) Bregs controls the expansion of lung effector T cells allowing the establishment of a favorable regulatory T cells/effector T cells ratio in lungs. CONCLUSION: This finding strengthens the potential for Breg-targeted therapies in allergic asthma.
BACKGROUND: Exposure to respiratory allergens triggers airway hyperresponsiveness and inflammation characterized by the expansion of TH 2 cells and the production of allergen specific IgE. Allergic asthma is characterized by an alteration in immune regulatory mechanisms leading to an imbalance between pro- and anti-inflammatory components of the immune system. AIMS: Recently B cells have been described as central regulators of exacerbated inflammation, notably in the case of autoimmunity. However, to what extent these cells can regulate airway inflammation and asthma remains to be elucidated. MATERIALS & METHODS: We took advantage of a allergic asthma model in mice induced by percutaneous sensitization and respiratory challenge with an extract of house dust mite. RESULTS: In this study, we showed that the induction of allergic asthma alters the homeostasis of IL-10(+) Bregs and favors the production of inflammatory cytokines by B cells. Deeper transcriptomic and phenotypic analysis of Bregs revealed that they were enriched in a CD9(+) B cell subset. In asthmatic mice the adoptive transfer of CD9(+) B cells normalized airway inflammation and lung function by inhibiting TH 2- and TH 17-driven inflammation in an IL-10-dependent manner, restoring a favorable immunological balance in lung tissues. Indeed we further showed that injection of CD9(+) Bregs controls the expansion of lung effector T cells allowing the establishment of a favorable regulatory T cells/effector T cells ratio in lungs. CONCLUSION: This finding strengthens the potential for Breg-targeted therapies in allergic asthma.
Authors: Sophina H Taitano; Luciën E P M van der Vlugt; Molly M Shea; Jennifer Yang; Nicholas W Lukacs; Steven K Lundy Journal: J Immunol Date: 2018-08-20 Impact factor: 5.422
Authors: Diego Catalán; Miguel Andrés Mansilla; Ashley Ferrier; Lilian Soto; Kristine Oleinika; Juan Carlos Aguillón; Octavio Aravena Journal: Front Immunol Date: 2021-04-29 Impact factor: 7.561
Authors: Arnaud Machelart; Georges Potemberg; Laurye Van Maele; Aurore Demars; Maxime Lagneaux; Carl De Trez; Catherine Sabatel; Fabrice Bureau; Sofie De Prins; Pauline Percier; Olivier Denis; Fabienne Jurion; Marta Romano; Jean-Marie Vanderwinden; Jean-Jacques Letesson; Eric Muraille Journal: Front Immunol Date: 2018-08-10 Impact factor: 7.561